Carbapenem-resistant Enterobacteriaceae (CRE) strains have become globally distributed in the past decade, resulting in concern over the control of hospital infections and antimicrobial therapies ([1][1], [2][2]). The majority of CRE… Click to show full abstract
Carbapenem-resistant Enterobacteriaceae (CRE) strains have become globally distributed in the past decade, resulting in concern over the control of hospital infections and antimicrobial therapies ([1][1], [2][2]). The majority of CRE isolates are carbapenemase-producing Enterobacteriaceae (CPE)
               
Click one of the above tabs to view related content.